{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:07:20Z","timestamp":1788214040815,"version":"build-2803163510"},"reference-count":70,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Progetto di Ricerca Ateneo Sapienza"},{"name":"POR FESR LAZIO 2014\/2020\u2014REGIONE LAZIO-Avviso pubblico LIFE"},{"name":"\u201cG. d\u2019Annunzio\u201d University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Human carbonic anhydrase (hCA, EC 4.2.1.1) isoforms IX and XII are overexpressed in solid hypoxic tumors, and they are considered as prognostic tools and therapeutic targets for cancer. Based on a molecular simplification of the well-known coumarin scaffold, we developed a new series of derivatives of the pyran-2-one core. The new compounds are endowed with potent and selective inhibitory activity against the tumor-related hCA isoforms IX and XII, in the low nanomolar range, whereas they are inactive against the two cytosolic off-targets hCA I and II. The compounds exhibiting the best hCA inhibition were further investigated against the breast adenocarcinoma cell line (MCF7) in hypoxic conditions, evaluating their ability to eventually synergize with doxorubicin. The compounds\u2019 biocompatibility on healthy cells was also tested and confirmed on Human Gingival Fibroblasts (HGFs). Furthermore, the possible binding mode of all compounds to the active site of the tumor-associated human CA IX was investigated by computational techniques which predicted the binding conformations and the persistency of binding poses within the active site of the enzyme, furnishing relevant data for the design of tight binding inhibitors.<\/jats:p>","DOI":"10.3390\/ijms23147950","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T08:28:25Z","timestamp":1658219305000},"page":"7950","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Novel Insights on Human Carbonic Anhydrase Inhibitors Based on Coumalic Acid: Design, Synthesis, Molecular Modeling Investigation, and Biological Studies"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3976-2291","authenticated-orcid":false,"given":"Virginia","family":"Pontecorvi","sequence":"first","affiliation":[{"name":"Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2398-1254","authenticated-orcid":false,"given":"Mattia","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-4228","authenticated-orcid":false,"given":"Francesca","family":"Picarazzi","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1705-6943","authenticated-orcid":false,"given":"Susi","family":"Zara","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-9440","authenticated-orcid":false,"given":"Simone","family":"Carradori","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Cataldi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7192","authenticated-orcid":false,"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[{"name":"NEUROFARBA Department, Pharmaceutical and Nutraceutical Section, University of Florence, Via Ugo Schiff 6, 50019 Florence, Italy"},{"name":"Department of Food and Drug, University of Parma, Parco Area delle Scienze, 27\/A, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4258-0678","authenticated-orcid":false,"given":"Emanuela","family":"Berrino","sequence":"additional","affiliation":[{"name":"Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Chimenti","sequence":"additional","affiliation":[{"name":"Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7538-2424","authenticated-orcid":false,"given":"Alessia","family":"Ciogli","sequence":"additional","affiliation":[{"name":"Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Secci","sequence":"additional","affiliation":[{"name":"Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Guglielmi","sequence":"additional","affiliation":[{"name":"Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"NEUROFARBA Department, Pharmaceutical and Nutraceutical Section, University of Florence, Via Ugo Schiff 6, 50019 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.37358\/RC.20.5.8107","article-title":"A Simple Yet Multifaceted Enzyme","volume":"71","author":"Supuran","year":"2020","journal-title":"Rev. Chim."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Supuran, C.T., and Capasso, C. (2017). An overview of the bacterial carbonic anhydrases. Metabolites, 7.","DOI":"10.3390\/metabo7040056"},{"key":"ref_3","first-page":"5266","article-title":"Are Carbonic Anhydrases Suitable Targets to Fight Protozoan Parasitic Diseases?","volume":"25","author":"Supuran","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Supuran, C.T., and Capasso, C. (2021). A highlight on the inhibition of fungal carbonic anhydrases as drug targets for the antifungal armamentarium. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094324"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1080\/14756366.2021.1972995","article-title":"An overview on the recently discovered iota-carbonic anhydrases","volume":"36","author":"Nocentini","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/14756366.2022.2038592","article-title":"Inhibition studies of bacterial \u03b1-carbonic anhydrases with phenols","volume":"37","author":"Giovannuzzi","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/14756366.2022.2036986","article-title":"Coumarins inhibit \u03b7-class carbonic anhydrase from Plasmodium falciparum","volume":"37","author":"Giovannuzzi","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/14756366.2016.1221826","article-title":"Identification and inhibition of carbonic anhydrases from nematodes","volume":"31","author":"Emameh","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1080\/14756366.2020.1828401","article-title":"Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: Design, synthesis, modelling investigations and biological activity evaluation","volume":"35","author":"Guglielmi","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Eysteinsson, T., Gudmundsdottir, H., Hardarson, A.O., Berrino, E., Selleri, S., Supuran, C.T., and Carta, F. (2019). Carbonic anhydrase inhibitors of different structures dilate pre-contracted porcine retinal arteries. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030467"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4155\/fmc-2021-0222","article-title":"Novel carbonic anhydrase inhibitors","volume":"13","author":"Supuran","year":"2021","journal-title":"Future Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/14756366.2019.1651315","article-title":"Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold","volume":"34","author":"Rotondi","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Supuran, C.T., and Nocentini, A. (2019). Carbonic anhydrase inhibitors for the treatment of epilepsy and obesity. Carbonic Anhydrases, Elsevier.","DOI":"10.1016\/B978-0-12-816476-1.00017-4"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"23068","DOI":"10.1002\/anie.202103211","article-title":"Modulating the Efficacy of Carbonic Anhydrase Inhibitors through Fluorine Substitution","volume":"60","author":"Berrino","year":"2021","journal-title":"Angew. Chem.-Int. Ed."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients with Advanced Solid Tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol. Cancer Clin. Trials"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-022-02345-x","article-title":"Inhibition of carbonic anhydrases IX\/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion","volume":"41","author":"Sarnella","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/14756366.2020.1764549","article-title":"The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells","volume":"35","author":"Peppicelli","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/17460441.2019.1567488","article-title":"Novel approaches for designing drugs that interfere with pH regulation","volume":"14","author":"Berrino","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1021\/acs.jmedchem.0c00636","article-title":"Azidothymidine \u201cclicked\u201d into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors","volume":"63","author":"Berrino","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/14756366.2020.1715388","article-title":"A class of carbonic anhydrase IX\/XII\u2013selective carboxylate inhibitors","volume":"35","author":"Alhameed","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1021\/acs.jmedchem.9b01434","article-title":"1,3-Dipolar Cycloaddition, HPLC Enantioseparation, and Docking Studies of Saccharin\/Isoxazole and Saccharin\/Isoxazoline Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors","volume":"63","author":"Secci","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1080\/14756366.2021.1945049","article-title":"Multitargeting approaches involving carbonic anhydrase inhibitors: Hybrid drugs against a variety of disorders","volume":"36","author":"Supuran","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1021\/acs.jmedchem.9b00845","article-title":"Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis","volume":"62","author":"Berrino","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1080\/14756366.2020.1822829","article-title":"Supuran, Toxicity evaluation of sulfamides and coumarins that efficiently inhibit human carbonic anhydrases","volume":"35","author":"Aspatwar","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1080\/14756366.2020.1788009","article-title":"Coumarin carbonic anhydrase inhibitors from natural sources","volume":"35","author":"Supuran","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1087057108315739","article-title":"Direct screening of natural product extracts using mass spectrometry","volume":"13","author":"Vu","year":"2008","journal-title":"J. Biomol. Screen."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: Coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/jm200983e","article-title":"Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors","volume":"54","author":"Touisni","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acsmedchemlett.8b00170","article-title":"Targeting Tumor Associated Carbonic Anhydrases IX and XII: Highly Isozyme Selective Coumarin and Psoralen Inhibitors","volume":"9","author":"Melis","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/j.bmcl.2010.06.040","article-title":"Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones i and II","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/jm301625s","article-title":"Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): A class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases","volume":"56","author":"Tars","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acs.jmedchem.5b01720","article-title":"Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins","volume":"59","author":"Ferraroni","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejmech.2019.04.072","article-title":"5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors","volume":"175","author":"Cornelio","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1016\/j.bmc.2017.04.007","article-title":"N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII","volume":"25","author":"Ivanova","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.bmc.2014.01.056","article-title":"Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII","volume":"22","author":"Carradori","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14756366.2016.1235040","article-title":"Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms","volume":"32","author":"Guglielmi","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/jm500255y","article-title":"Cyclic secondary sulfonamides: Unusually good inhibitors of cancer-related carbonic anhydrase enzymes","volume":"57","author":"Moeker","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Cau, Y., Vullo, D., Mori, M., Dreassi, E., Supuran, C.T., and Botta, M. (2018). Potent and selective carboxylic acid inhibitors of tumor-associated carbonic anhydrases IX and XII. Molecules, 23.","DOI":"10.3390\/molecules23010017"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"113875","DOI":"10.1016\/j.ejmech.2021.113875","article-title":"Binding site comparison for coumarin inhibitors and amine\/amino acid activators of human carbonic anhydrases","volume":"226","author":"Petreni","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/14756366.2021.1882453","article-title":"Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase","volume":"36","author":"Nocentini","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Berrino, E., Bua, S., Mori, M., Botta, M., Murthy, V.S., Vijayakumar, V., Tamboli, Y., Bartolucci, G., Mugelli, A., and Cerbai, E. (2017). Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors. Molecules, 22.","DOI":"10.3390\/molecules22071049"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1039\/C6OB01477A","article-title":"Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: Kinetic and computational investigations","volume":"14","author":"Cau","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1021\/acschembio.5b00337","article-title":"Hit Recycling: Discovery of a Potent Carbonic Anhydrase Inhibitor by in Silico Target Fishing","volume":"10","author":"Mori","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The Carbon Dioxide Hydration Activity of Carbonic Anhydrase","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.bioorg.2019.03.062","article-title":"Sulfur, selenium and tellurium containing amines act as effective carbonic anhydrase activators","volume":"87","author":"Tanini","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bioorg.2019.03.003","article-title":"Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma","volume":"87","author":"Kurt","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/14756366.2017.1375485","article-title":"Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII","volume":"32","author":"Angeli","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_53","first-page":"651","article-title":"Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study","volume":"42","author":"Tortorella","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: A worldwide hub of protein knowledge","volume":"47","author":"Bateman","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_55","first-page":"1","article-title":"Kinesins and cancer","volume":"12","author":"Kozielski","year":"2015","journal-title":"Kinesins Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: Algorithm and validation using high quality structures from the protein databank and cambridge structural database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jb\/mvz015","article-title":"Morelloflavone as a novel inhibitor of mitotic kinesin Eg5","volume":"166","author":"Ogunwa","year":"2019","journal-title":"J. Biochem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1158\/0008-5472.CAN-17-2066","article-title":"Recent advances of cell-cycle inhibitor therapies for pediatric cancer","volume":"77","author":"Mills","year":"2017","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/1759-7714.12792","article-title":"Non-canonical functions of the mitotic kinesin Eg5","volume":"9","author":"Liu","year":"2018","journal-title":"Thorac. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved Protein-Ligand Docking Using GOLD","volume":"54","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and Validation of a Genetic Algorithm for Flexible Docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/wcms.1121","article-title":"An overview of the Amber biomolecular simulation package","volume":"3","author":"Case","year":"2013","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1021\/ci100070m","article-title":"Molecular dynamics and DFT study on HIV-1 nucleocapsid protein-7 in complex with viral genome","volume":"50","author":"Mori","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1021\/cb500316h","article-title":"Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity","volume":"9","author":"Mori","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/acsmedchemlett.8b00506","article-title":"Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein","volume":"10","author":"Mori","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1021\/acs.jcim.0c00722","article-title":"Experimental and Computational Druggability Exploration of the 14-3-3\u03b6\/SOS1pS1161PPI Interface","volume":"60","author":"Ballone","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8106","DOI":"10.1002\/ange.201601688","article-title":"Tautomers of a Fluorescent G Surrogate and Their Distinct Photophysics Provide Additional Information Channels","volume":"128","author":"Sholokh","year":"2016","journal-title":"Angew. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16999","DOI":"10.1021\/jacs.0c06165","article-title":"What makes thienoguanosine an outstanding fluorescent DNA probe?","volume":"142","author":"Kuchlyan","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"McDonald, P.C., Chafe, S.C., Supuran, C.T., and Dedhar, S. (2022). Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside. Cancers, 14.","DOI":"10.3390\/cancers14143297"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/14\/7950\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:53:45Z","timestamp":1760140425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/14\/7950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":70,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["ijms23147950"],"URL":"https:\/\/doi.org\/10.3390\/ijms23147950","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]}}}